All News

New approaches are needed for predicting the safe dose of novel drugs that are designed to interact with highly specific human targets because existing preclinical toxicology studies may be inadequate.

We applaud a rare bout of honesty.

The IP battlefield is large and diversified. It goes way beyond highly-publicized battles about patenting genes or semi-conductor designs. A case in point is a lawsuit filed July 14 by Materialise nv, a spin-off of Belgium’s Katholieke Universiteit Leuven, against a Swiss-Swedish company, Nobel Biocare.

The EU is surveying the remuneration of researchers.

You have until the end of the month to tell the EU about your "needs in relation to transnational research cooperation and knowledge transfer between public research organisations".

Medical research should benefit from new lectureships for experts in clinical trials.

The European Union’s €54 billion research budget for the next seven years may not be approved in time for the beginning of next year – if Slovenia carries out its threat to oppose the funding of stem cell research.

The technology-transfer unit of Imperial College London, continuing preparations for its stock-market debut on 31 July, said it has completed a £25 million private placement and set a public share price that would value the business at £181 million.

China has now set its sights on developing its scientific prowess in the same way - and at the same rate – as it has modernised its economy.

The stock-market debut at the end of July of Imperial College London’s tech-transfer office is the best news for academic reform in years.

Norwegian researchers want to commercialise an easy-to-use technology that diagnoses the cause of snoring and measures the effectiveness of treatments.

Researchers developing compounds designed to prevent allergens from entering the body are seeking investment to move to the next stage of development.

Two companies that began life in laboratories at Cambridge University have merged to form a new medical diagnostics company, to be called Pronostics Ltd.

The pressing need for alternative energy sources is driving investment into nanotechnology devices for energy applications such as photovoltaic solar cells.